These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11831500)

  • 21. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 22. Methamphetamine and meth mouth: an overview.
    Williams N; Covington JS
    J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
    [No Abstract]   [Full Text] [Related]  

  • 23. Prosthodontics treatment considerations for methamphetamine-dependent patients.
    Gantos MA; Manzotti A; Yuan JC; Afshari FS; Marinis A; Syros G; Rynn MH; Sukotjo C
    J Prosthodont; 2015 Jan; 24(1):64-70. PubMed ID: 25627552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems.
    Lim MS; Cogger S; Quinn B; Hellard ME; Dietze PM
    Aust N Z J Public Health; 2015 Apr; 39(2):194-5. PubMed ID: 25559677
    [No Abstract]   [Full Text] [Related]  

  • 25. American Indian methamphetamine and other drug use in the Southwestern United States.
    Forcehimes AA; Venner KL; Bogenschutz MP; Foley K; Davis MP; Houck JM; Willie EL; Begaye P
    Cultur Divers Ethnic Minor Psychol; 2011 Oct; 17(4):366-76. PubMed ID: 21988577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women with methamphetamine dependence: research on etiology and treatment.
    Cohen JB; Greenberg R; Uri J; Halpin M; Zweben JE
    J Psychoactive Drugs; 2007 Nov; Suppl 4():347-51. PubMed ID: 18284101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between impulsivity and methamphetamine use severity in a community sample.
    Moallem NR; Courtney KE; Ray LA
    Drug Alcohol Depend; 2018 Jun; 187():1-7. PubMed ID: 29626740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major physical and psychological harms of methamphetamine use.
    Darke S; Kaye S; McKetin R; Duflou J
    Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction.
    Li MD; Wang J; Niu T; Ma JZ; Seneviratne C; Ait-Daoud N; Saadvandi J; Morris R; Weiss D; Campbell J; Haning W; Mawhinney DJ; Weis D; McCann M; Stock C; Kahn R; Iturriaga E; Yu E; Elkashef A; Johnson BA
    BMC Med Genomics; 2014 Dec; 7():65. PubMed ID: 25495887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of long-term consequences of maternal methamphetamine exposure.
    Šlamberová R
    Physiol Res; 2019 Dec; 68(Suppl 3):S219-S231. PubMed ID: 31928040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methamphetamine use in Dayton, Ohio: preliminary findings from the Ohio Substance Abuse Monitoring Network.
    Daniulaityte R; Carlson RG; Kenne DR
    J Psychoactive Drugs; 2007 Sep; 39(3):211-21. PubMed ID: 18159774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine abuse: medical and dental considerations.
    Smart RJ; Rosenberg M
    J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.
    Kalechstein AD; Newton TF; Longshore D; Anglin MD; van Gorp WG; Gawin FH
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):480-4. PubMed ID: 11083165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METHAMPHETAMINE: WHERE WILL THE STAMPEDE TAKE US?
    Sullivan D; McDonough Michael
    J Law Med; 2015 Sep; 23(1):41-9. PubMed ID: 26554196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioids and methamphetamine: a tale of two crises.
    The Lancet
    Lancet; 2018 Feb; 391(10122):713. PubMed ID: 29486928
    [No Abstract]   [Full Text] [Related]  

  • 39. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia.
    Chalmers J; Lancaster K; Hughes C
    Int J Drug Policy; 2016 Oct; 36():15-24. PubMed ID: 27450550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.